285 related articles for article (PubMed ID: 10989821)
1. Linezolid--a new option for treating gram-positive infections.
Batts DH
Oncology (Williston Park); 2000 Aug; 14(8 Suppl 6):23-9. PubMed ID: 10989821
[TBL] [Abstract][Full Text] [Related]
2. Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant gram-positive bacterial pathogens.
Jantausch BA; Deville J; Adler S; Morfin MR; Lopez P; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S164-71. PubMed ID: 14520142
[TBL] [Abstract][Full Text] [Related]
3. [Linezolid, an agent from a new class of antibiotics].
Kuijper EJ; Schippers EF; Bernards AT
Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
[TBL] [Abstract][Full Text] [Related]
4. Linezolid versus vancomycin in the treatment of known or suspected resistant gram-positive infections in neonates.
Deville JG; Adler S; Azimi PH; Jantausch BA; Morfin MR; Beltran S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S158-63. PubMed ID: 14520141
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of linezolid in liver transplant patients.
Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
[TBL] [Abstract][Full Text] [Related]
6. [The first clinical experiences in Hungary with a new effective antibiotic (linezolid) effective against Gram-positive infections].
Pulay I; Konkoly TM; Zsirka KA; Csapó Z; Flautner L; Tihanyi T
Orv Hetil; 2003 Jan; 144(1):29-33. PubMed ID: 12635350
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
Manfredi R
Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
[TBL] [Abstract][Full Text] [Related]
8. Linezolid: implications for neurosurgical infections.
Nguyen CM; Larive LL; Rhoney DH
Neurol Res; 2003 Jan; 25(1):22-6. PubMed ID: 12564121
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.
Plouffe JF
Clin Infect Dis; 2000 Sep; 31 Suppl 4():S144-9. PubMed ID: 11017864
[TBL] [Abstract][Full Text] [Related]
10. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and postoperative gram-positive infections.
Wilson SE
Surg Infect (Larchmt); 2001; 2(1):25-35. PubMed ID: 12594878
[TBL] [Abstract][Full Text] [Related]
12. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
13. Treatment of prosthetic valve infective endocarditis due to multi-resistant Gram-positive bacteria with linezolid.
Wareham DW; Abbas H; Karcher AM; Das SS
J Infect; 2006 Apr; 52(4):300-4. PubMed ID: 16099052
[TBL] [Abstract][Full Text] [Related]
14. Experience with linezolid therapy in children with osteoarticular infections.
Chen CJ; Chiu CH; Lin TY; Lee ZL; Yang WE; Huang YC
Pediatr Infect Dis J; 2007 Nov; 26(11):985-8. PubMed ID: 17984803
[TBL] [Abstract][Full Text] [Related]
15. Linezolid for the treatment of complicated skin and skin structure infections in children.
Yogev R; Patterson LE; Kaplan SL; Adler S; Morfin MR; Martin A; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S172-7. PubMed ID: 14520143
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of linezolid versus comparator therapies in Gram-positive infections.
Wilcox MH
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii27-35. PubMed ID: 12730140
[TBL] [Abstract][Full Text] [Related]
17. Oxazolidinones--a new class of broad-spectrum chemotherapeutics.
Sztanke K; Pasternak K; Sztanke M
Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):335-41. PubMed ID: 16146103
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistance.
Segreti J
Clin Microbiol Infect; 2005 May; 11 Suppl 3():29-35. PubMed ID: 15811022
[TBL] [Abstract][Full Text] [Related]
19. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid].
Krueger WA; Unertl KE
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of linezolid in children.
Saiman L; Goldfarb J; Kaplan SA; Wible K; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S193-200. PubMed ID: 14520146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
